Subunit vaccine with MUC1 tandem repeats and MBP/BCG adjuvant induced Th1 immune response (66), activation of NK cells, and MUC1-specific CTL in mouse models of melanoma and lung carcinoma (67). This evidence concerns the gene MUC1 and lung carcinoma.